Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival. Article Swipe
Jonathan Gootee
,
Christina Curtin
,
Sarah Aurit
,
Saboor Ejaz Randhawa
,
Bianca Y. Kang
,
Peter T. Silberstein
·
YOU?
·
· 2019
· Open Access
·
YOU?
·
· 2019
· Open Access
·
A National Cancer Database study of on survival outcomes for patients with dedifferentiated liposarcomas found that insurance status, median household income, and treatment facility were associated with differences in median survival and 5- and 10-year survival probabilities.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://pubmed.ncbi.nlm.nih.gov/31507311
- OA Status
- green
- Cited By
- 10
- References
- 14
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2990007356
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2990007356Canonical identifier for this work in OpenAlex
- Title
-
Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival.Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-08-01Full publication date if available
- Authors
-
Jonathan Gootee, Christina Curtin, Sarah Aurit, Saboor Ejaz Randhawa, Bianca Y. Kang, Peter T. SilbersteinList of authors in order
- Landing page
-
https://pubmed.ncbi.nlm.nih.gov/31507311Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/6719806Direct OA link when available
- Concepts
-
Overall survival, Liposarcoma, Medicine, Proportional hazards model, Oncology, Survival analysis, Internal medicine, Demography, Sarcoma, Pathology, SociologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
10Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 4, 2021: 1, 2020: 1Per-year citation counts (last 5 years)
- References (count)
-
14Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2990007356 |
|---|---|
| doi | |
| ids.mag | 2990007356 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31507311 |
| ids.openalex | https://openalex.org/W2990007356 |
| fwci | 0.41049196 |
| type | article |
| title | Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival. |
| biblio.issue | Suppl 5 |
| biblio.volume | 36 |
| biblio.last_page | S41 |
| biblio.first_page | S34 |
| topics[0].id | https://openalex.org/T10253 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Sarcoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10185 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9943000078201294 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Lymphoma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T11287 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9793000221252441 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1306 |
| topics[2].subfield.display_name | Cancer Research |
| topics[2].display_name | Cancer Genomics and Diagnostics |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3019894029 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6362025737762451 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q332823 |
| concepts[0].display_name | Overall survival |
| concepts[1].id | https://openalex.org/C2779568860 |
| concepts[1].level | 3 |
| concepts[1].score | 0.612826406955719 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1827425 |
| concepts[1].display_name | Liposarcoma |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.541298508644104 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C50382708 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4809921979904175 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q223218 |
| concepts[3].display_name | Proportional hazards model |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4790286123752594 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C10515644 |
| concepts[5].level | 2 |
| concepts[5].score | 0.46618080139160156 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q543310 |
| concepts[5].display_name | Survival analysis |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.42050477862358093 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C149923435 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3842226266860962 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q37732 |
| concepts[7].display_name | Demography |
| concepts[8].id | https://openalex.org/C2778256501 |
| concepts[8].level | 2 |
| concepts[8].score | 0.14524343609809875 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q223911 |
| concepts[8].display_name | Sarcoma |
| concepts[9].id | https://openalex.org/C142724271 |
| concepts[9].level | 1 |
| concepts[9].score | 0.13060876727104187 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[9].display_name | Pathology |
| concepts[10].id | https://openalex.org/C144024400 |
| concepts[10].level | 0 |
| concepts[10].score | 0.05297556519508362 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q21201 |
| concepts[10].display_name | Sociology |
| keywords[0].id | https://openalex.org/keywords/overall-survival |
| keywords[0].score | 0.6362025737762451 |
| keywords[0].display_name | Overall survival |
| keywords[1].id | https://openalex.org/keywords/liposarcoma |
| keywords[1].score | 0.612826406955719 |
| keywords[1].display_name | Liposarcoma |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.541298508644104 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/proportional-hazards-model |
| keywords[3].score | 0.4809921979904175 |
| keywords[3].display_name | Proportional hazards model |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.4790286123752594 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/survival-analysis |
| keywords[5].score | 0.46618080139160156 |
| keywords[5].display_name | Survival analysis |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.42050477862358093 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/demography |
| keywords[7].score | 0.3842226266860962 |
| keywords[7].display_name | Demography |
| keywords[8].id | https://openalex.org/keywords/sarcoma |
| keywords[8].score | 0.14524343609809875 |
| keywords[8].display_name | Sarcoma |
| keywords[9].id | https://openalex.org/keywords/pathology |
| keywords[9].score | 0.13060876727104187 |
| keywords[9].display_name | Pathology |
| keywords[10].id | https://openalex.org/keywords/sociology |
| keywords[10].score | 0.05297556519508362 |
| keywords[10].display_name | Sociology |
| language | en |
| locations[0].id | pmid:31507311 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4306525036 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | PubMed |
| locations[0].source.host_organization | https://openalex.org/I1299303238 |
| locations[0].source.host_organization_name | National Institutes of Health |
| locations[0].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Federal practitioner : for the health care professionals of the VA, DoD, and PHS |
| locations[0].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31507311 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:6719806 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Fed Pract |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6719806 |
| indexed_in | pubmed |
| authorships[0].author.id | https://openalex.org/A5050516852 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0260-9189 |
| authorships[0].author.display_name | Jonathan Gootee |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I114493937 |
| authorships[0].affiliations[0].raw_affiliation_string | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[0].institutions[0].id | https://openalex.org/I114493937 |
| authorships[0].institutions[0].ror | https://ror.org/05wf30g94 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I114493937 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Creighton University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jonathan Michael Gootee |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[1].author.id | https://openalex.org/A5000733589 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Christina Curtin |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I114493937 |
| authorships[1].affiliations[0].raw_affiliation_string | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[1].institutions[0].id | https://openalex.org/I114493937 |
| authorships[1].institutions[0].ror | https://ror.org/05wf30g94 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I114493937 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Creighton University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Christina E Curtin |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[2].author.id | https://openalex.org/A5020346806 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Sarah Aurit |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I114493937 |
| authorships[2].affiliations[0].raw_affiliation_string | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[2].institutions[0].id | https://openalex.org/I114493937 |
| authorships[2].institutions[0].ror | https://ror.org/05wf30g94 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I114493937 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Creighton University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sarah J Aurit |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[3].author.id | https://openalex.org/A5018183003 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Saboor Ejaz Randhawa |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I114493937 |
| authorships[3].affiliations[0].raw_affiliation_string | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[3].institutions[0].id | https://openalex.org/I114493937 |
| authorships[3].institutions[0].ror | https://ror.org/05wf30g94 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I114493937 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Creighton University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Saboor E Randhawa |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[4].author.id | https://openalex.org/A5079216560 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9373-2555 |
| authorships[4].author.display_name | Bianca Y. Kang |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I114493937 |
| authorships[4].affiliations[0].raw_affiliation_string | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[4].institutions[0].id | https://openalex.org/I114493937 |
| authorships[4].institutions[0].ror | https://ror.org/05wf30g94 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I114493937 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Creighton University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Bianca Y Kang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[5].author.id | https://openalex.org/A5061188498 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Peter T. Silberstein |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I114493937 |
| authorships[5].affiliations[0].raw_affiliation_string | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| authorships[5].institutions[0].id | https://openalex.org/I114493937 |
| authorships[5].institutions[0].ror | https://ror.org/05wf30g94 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I114493937 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Creighton University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Peter T Silberstein |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | , and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6719806 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival. |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T04:12:42.849631 |
| primary_topic.id | https://openalex.org/T10253 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Sarcoma Diagnosis and Treatment |
| related_works | https://openalex.org/W3011827526, https://openalex.org/W77834705, https://openalex.org/W4285594075, https://openalex.org/W1986660132, https://openalex.org/W2337677096, https://openalex.org/W4321017828, https://openalex.org/W1845943907, https://openalex.org/W3012824765, https://openalex.org/W4290888890, https://openalex.org/W4312113682 |
| cited_by_count | 10 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2021 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2020 |
| counts_by_year[3].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:6719806 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Fed Pract |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6719806 |
| primary_location.id | pmid:31507311 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4306525036 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | PubMed |
| primary_location.source.host_organization | https://openalex.org/I1299303238 |
| primary_location.source.host_organization_name | National Institutes of Health |
| primary_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Federal practitioner : for the health care professionals of the VA, DoD, and PHS |
| primary_location.landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31507311 |
| publication_date | 2019-08-01 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2084302982, https://openalex.org/W2755349712, https://openalex.org/W2011653982, https://openalex.org/W2732577883, https://openalex.org/W2774422690, https://openalex.org/W2765314273, https://openalex.org/W2042472927, https://openalex.org/W1980141070, https://openalex.org/W2057660831, https://openalex.org/W4210469663, https://openalex.org/W2148135319, https://openalex.org/W1977767602, https://openalex.org/W2067366670, https://openalex.org/W2073533521 |
| referenced_works_count | 14 |
| abstract_inverted_index.A | 0 |
| abstract_inverted_index.5- | 32 |
| abstract_inverted_index.in | 28 |
| abstract_inverted_index.of | 5 |
| abstract_inverted_index.on | 6 |
| abstract_inverted_index.and | 21, 31, 33 |
| abstract_inverted_index.for | 9 |
| abstract_inverted_index.that | 15 |
| abstract_inverted_index.were | 24 |
| abstract_inverted_index.with | 11, 26 |
| abstract_inverted_index.found | 14 |
| abstract_inverted_index.study | 4 |
| abstract_inverted_index.Cancer | 2 |
| abstract_inverted_index.median | 18, 29 |
| abstract_inverted_index.10-year | 34 |
| abstract_inverted_index.income, | 20 |
| abstract_inverted_index.status, | 17 |
| abstract_inverted_index.Database | 3 |
| abstract_inverted_index.National | 1 |
| abstract_inverted_index.facility | 23 |
| abstract_inverted_index.outcomes | 8 |
| abstract_inverted_index.patients | 10 |
| abstract_inverted_index.survival | 7, 30, 35 |
| abstract_inverted_index.household | 19 |
| abstract_inverted_index.insurance | 16 |
| abstract_inverted_index.treatment | 22 |
| abstract_inverted_index.associated | 25 |
| abstract_inverted_index.differences | 27 |
| abstract_inverted_index.liposarcomas | 13 |
| abstract_inverted_index.probabilities. | 36 |
| abstract_inverted_index.dedifferentiated | 12 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.5899999737739563 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.66956986 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |